Skip to main content
. Author manuscript; available in PMC: 2022 Dec 6.
Published in final edited form as: J Cyst Fibros. 2021 Nov 22;21(6):996–1005. doi: 10.1016/j.jcf.2021.11.003

Fig. 2.

Fig. 2.

Microbiome changes throughout ETI therapy. a) Taxonomic dynamics at the family level of ASVs in each subject before (N) and after (T) ETI therapy. b) The rRNA copies/mL of sputum, log-ratio of pathogen:anaerobes and ASV dynamics before and after ETI therapy.